Revolution Medicines's market cap is currently $7.56B. The company's EPS TTM is $-3.591; its P/E ratio is ―; Revolution Medicines is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-0.99. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 11.58M	$ 35.38M	$ 29.39M	$ 42.98M	$ 50.04M
Gross Profit	$ 11.58M	$ 25.72M	$ 22.06M	$ -89.27M	$ -41.71M
Operating Income	$ -487.19M	$ -258.28M	$ -188.01M	$ -110.70M	$ -54.12M
EBITDA	$ -430.58M	$ -239.47M	$ -179.75M	$ -101.91M	$ -48.59M
Net Income	$ -436.37M	$ -248.71M	$ -179.77M	$ -108.16M	$ -47.66M
Balance Sheet
Cash & Short-Term Investments	$ 1.85B	$ 644.94M	$ 577.05M	$ 440.74M	$ 122.76M
Total Assets	$ 2.06B	$ 811.93M	$ 737.99M	$ 567.40M	$ 220.53M
Total Debt	$ 87.94M	$ 64.20M	$ 66.63M	$ 32.66M	$ 172.00K
Net Debt	$ -608.20M	$ -97.21M	$ -41.86M	$ -71.60M	$ -16.49M
Total Liabilities	$ 235.51M	$ 126.74M	$ 135.42M	$ 92.72M	$ 67.99M
Stockholders' Equity	$ 1.83B	$ 685.19M	$ 602.57M	$ 474.68M	$ 152.53M
Cash Flow
Free Cash Flow	$ -358.30M	$ -235.22M	$ -153.71M	$ -103.00M	$ -52.20M
Operating Cash Flow	$ -350.57M	$ -224.40M	$ -147.18M	$ -100.06M	$ -49.62M
Investing Cash Flow	$ -342.60M	$ -24.12M	$ -142.12M	$ -234.23M	$ -101.97M
Financing Cash Flow	$ 1.23B	$ 301.43M	$ 294.18M	$ 422.78M	$ 98.66M

Currency in USD

Revolution Medicines Earnings and Revenue History

Income Statement >

Revolution Medicines Debt to Assets

Balance Sheet >

Revolution Medicines Cash Flow

Cash Flow >

Revolution Medicines Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing